Profound Medical (PROF) Equity Average (2019 - 2026)

Profound Medical has reported Equity Average for 8 years, with the latest figure at $62.9 million in Q1 2026.

• For the quarter ending Q1 2026, Equity Average rose 13.17% year-over-year to $62.9 million; the trailing twelve-month figure through Mar 2026 stood at $62.9 million (up 13.17% YoY), and the FY2025 full-year result was $63.4 million, up 38.42% from the prior year.
• Equity Average for Q1 2026 stood at $62.9 million, up from $49.3 million in the prior quarter.
• The five-year high for Equity Average was $37.3 billion in Q1 2022, with the low at $34.8 million in Q3 2024.
• Average Equity Average over 5 years is $7.3 billion, with a median of $49.3 million recorded in 2025.
• Year-over-year, Equity Average sank 99.84% in 2024 and jumped 44.92% in 2025.
• Tracing PROF's Equity Average over 5 years: stood at $56.4 million in 2022, then sank by 38.09% to $34.9 million in 2023, then surged by 30.6% to $45.6 million in 2024, then climbed by 8.16% to $49.3 million in 2025, then gained by 27.67% to $62.9 million in 2026.
• The last three Equity Average figures came in at $62.9 million (Q1 2026), $49.3 million (Q4 2025), and $35.7 million (Q3 2025), per Business Quant data.

Peer Comparison